Sera Prognostics, Inc.

US$2.19As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:SERAHealthcare
Country USA
PE (Fwd) •••
TSR 5Y CAGR (26.66%)
Div yield —
ROE (49.73%)
Medical Devices
Beta (5Y) 1.15
PE TTM —
TSR TTM (33.23%)
Mkt cap US$86.39M
ROIC (33.20%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$2.29
4.64%
86.85%
Hold 6|2|5|4|7
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.02
0.02
0.02
0.03
(5.73%)
8.50%
8.08%
17.40%
Revenue$M
11.37
12.04
12.65
12.28
11.32%
11.18%
11.96%
9.08%
Peers (US$86.39M)
Cap (US$)
PE
76.30M
—
86.22M
—
Capital
TTM
5Y
10Y
Leveragex
1.042
0.062
0.061
EBIT/Intx
1.483
0.474
0.377
Own earn%
0.14
68.51
46.31
Sh yield%
12.42
34.00
32.95
Owners
Insiders/Inst%
11.42
79.15
Short interest%
2.32
SBC / revenue%
5.06
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
16
Op margin range%
4–12
$1 testx
—
Incr. ROIC%
9